Search

Objective To investigate the expression and clinical significance of silent information regulator 2 (SIRT2) form tissue of urothelial bladder cancer(UBC) and the effects of down-regulation of SIRT2 on the proliferation, invasion and migration of bladder cancer cells. Methods The expression of SIRT2 protein was detected in 95 samples of urothelial bladder cancer tissues and 39 paracancerous tissues using the immunohistochemical EnVision method. Its relationship with clinicopathological parameters was analyzed. The expression of SIRT2 mRNA in bladder cancer cell lines was detected by RT-qPCR, and the expression levels of SIRT2 protein in bladder cancer cell lines, 12 pairs of fresh bladder cancer tissues were detected by Western blot. Lentiviral infection was used to stably downregulate the SIRT2 gene in bladder cancer cell line T24. CCK8 and cell colony assays were performed to detect changes in cell proliferation ability and Transwell assay to detect changes in cell invasion and migration activity. Results The positive expression rate of SIRT2 in urothelial bladder cancer tissues was 84%(80/95), which was higher than that in normal uroepithelial tissues (5%, 2/39) (PConclusions SIRT2 is highly expressed in bladder uroepithelial carcinoma, and interfers with SIRT2 significantly and so inhibites bladder cancer cell proliferation, invasion and migration.

The issues of teaching innovation and entrepreneurship to college students in higher education institutions are first examined in this research, respectively, in terms of practical activities, evaluation system, and faculty strength. Based on the CIPP theory, the assessment framework for innovation and entrepreneurial education was developed, and the redundant indexes were screened by using the improved hierarchical analysis method. Secondly, the AHM-GRA model was used to conduct an in-depth analysis of the innovation and entrepreneurship curriculum at higher education institutions. Finally, the index system was empirically analyzed through gray correlation analysis. The results show that, on average, the approach utilized in this work performs 12.67% better than the fuzzy comprehensive assessment. With the help of this methodology, higher education institutions may assess their current level of innovation and entrepreneurship instruction and strive to improve it.

BACKGROUND Hexavalent chromium Cr(Ⅵ) is one of the basic monitoring indicators of soil in construction land. It is of great significance to carry out soil hexavalent chromium monitoring in the prevention and control of environmental pollution. At present, the standard method of hexavalent chromium in soil is flame atomic absorption spectrometry (FAAS). The FAAS method has a high detection limit (0.5mg/kg), and serious matrix effect, and cannot meet the analysis of Cr(Ⅵ) in low-concentration soil samples. OBJECTIVES To establish a convenient and high sensitivity method for determination of low-concentration hexavalent chromium in soil. METHODS An ion-exchange-inductively coupled plasma-mass spectrometry (ICP-MS) method was developed to determine the content of hexavalent chromium in soil by extracting hexavalent chromium with alkali solution. The resin content, mixing speed, extraction temperature and extraction time were studied. The measurement results were compared with the flame atomic absorption spectrophotometry (FAAS) method. RESULTS The results showed that the total dissolved solids (TDS) mass fraction was reduced from 2.4% to 0.17% after the alkaline extraction solution was diluted 10 times and 3.5g of cation exchange resin was added, and the matrix interference was greatly reduced. At the same time, due to the dissolution of hydrogen ions in the ion exchange process, the pH reached a suitable detection range (7.5±0.5). The pretreatment conditions were optimized. When the extraction temperature was 90-95℃, the stirring speed was 300 rpm, and the heating time was 70 min, the extraction effect of Cr(Ⅵ) was the best, and the relative error was -1.7%. The relative standard deviation (RSD) was 3.1%-5.9%, and the average relative error was -3.8% to -1.1%. F test and t test were used to compare the test results of high, medium and low concentration standard substances by ICP-MS and FAAS, and there was no significant difference between the two methods. The method detection limit (MDL) was 0.061 mg/kg. CONCLUSIONS Since this method adopts dilution, ion exchange, internal standard method, to reduce matrix interference, combined with the high sensitivity and good accuracy of ICP-MS, the method detection limit (MDL) is significantly lower than the detection limit of FAAS method (0.5mg/kg). This method can be used for the determination of low-concentration soil Cr(Ⅵ) samples.

To date, only 34 cases of primary pulmonary rhabdomyosarcoma (PPRMS) in the middle-aged and elderly population have been published. However, analyses of the clinicopathological characteristics and prognosis of PPRMS in this population have not been performed. A 75-year-old man visited our hospital because of abdominal pain and discomfort. His serum lactate dehydrogenase, neuron specific enolase, and progastrin-releasing peptide levels were elevated. Positron emission tomography–computed tomography revealed a lobulated mass of 7.6 × 5.5 cm 2 in the lower lobe of the left lung with abnormally high fluoro-2-deoxy- d -glucose metabolism. Histologically, the tumor cells were small with little cytoplasm, deep nuclear staining, and heavily stained nuclear chromatin. Immunohistochemically, the tumor cells were positive for desmin, MyoD1 myogenin, synaptophysin, and CD56. Cytogenetic analysis for FOXO1A translocation was negative. Finally, the patient was diagnosed with PPRMS. He received combined chemotherapy with vincristine 1 mg, actinomycin 0.4 mg, cyclophosphamide 0.8 mg; however, only one course of chemotherapy was completed, and the patient died 2 months after diagnosis. PPRMS in middle-aged and elderly people is a highly malignant soft tissue tumor with significant clinicopathological characteristics.

CDK4/6 are important regulators of cell cycle and their inhibitors have been approved as anti-cancer drugs. Here, we report a STING-dependent anti-tumor immune mechanism responsible for tumor suppression by CDK4/6 blockade. Clinical datasets show that in human tissues, CDK4 and CDK6 are over-expressed and their expressions are negatively correlated with patients overall survival and T cell infiltration. Deletion of Cdk4 or Cdk6 in tumor cells significantly reduce tumor growth. Mechanistically, we find that Cdk4 or Cdk6 deficiency contributes to an increased level of endogenous DNA damage, which triggers the cGAS-STING signaling pathway to activate type I interferon response. Knockout of Sting is sufficient to reverse and partially reverse the anti-tumor effect of Cdk4 and Cdk6 deficiency respectively. Therefore, our findings suggest that CDK4/6 inhibitors may enhance anti-tumor immunity through the STING-dependent type I interferon response.

Background: Previous studies have demonstrated that the glycolytic enzyme phosphoglycerate kinase 1 (PGK1) can promote tumor development. This study sought to investigate the specific role of PGK1 in bladder cancer (BLCA). Methods: Public databases and immunohistochemistry assays were utilized to analyze the expression of PGK1 in BLCA and its prognostic significance. Cell proliferation was assessed through CCK‐8 and colony formation assays, while the level of metastasis was evaluated using transwell migration experiments. Additionally, IC50 experiments were conducted to assess the impact of PGK1 on cisplatin sensitivity. Results: The mRNA and protein expression levels of PGK1 were significantly upregulated in BLCA. Cox proportional hazards model analysis revealed that PGK1 and T stage were independent prognostic factors for BLCA patients. Both CCK‐8 and colony assays demonstrated that PGK1 promotes proliferation. Furthermore, a positive correlation was observed between PGK1 and Ki67, a proliferation index. Transwell migration assays confirmed the ability of PGK1 to enhance metastasis. Finally, PGK1 increased the IC50 associated with cisplatin treatment in BLCA. Conclusion: Collectively, these findings suggest that PGK1 may hold clinical value in predicting BLCA prognosis and improving the outcomes of this patient population. [ABSTRACT FROM AUTHOR]

Background: Cervical cancer (CC) is a serious global disease with poor prognoses and a significant recurrence rate in patients with advanced disease. Oxidative stress (OS) greatly influences many types of human cancers, making it crucial to understand the functional mechanisms of OS‐related genes in CC. Methods: The transcriptome and clinical data of three normal samples and 306 patients with CC were obtained from The Cancer Genome Atlas dataset. The GSE44001 dataset was acquired from the Gene Expression Omnibus database. OS‐related subtypes in the cohort with CC were identified using unsupervised hierarchical clustering, univariate Cox analysis, gene set enrichment analysis (GSEA), and least absolute shrinkage and selection operator regression analysis. Additionally, molecular pathways that differ across subtypes were determined and OS‐related genes linked to the prognosis of patients of CC were determined. Finally, a clinical prognostic gene signature was developed and validated. The relative infiltration level of immune cell subpopulations in different risk groups and subtypes was evaluated using the cell‐type identification by estimating relative subsets of RNA transcripts (CIBERPORT) algorithm and single‐sample GSEA (ssGSEA) techniques. Results: The present study established two distinct OS subtypes (OS clusters A and B). Analysis using ssGSEA and CIBERSPORT revealed that OS cluster B exhibited a significant level of immune infiltration. A clinical prognostic gene signature was established using OS‐related characteristic genes identified by examining the differentially expressed genes across both subtypes. Furthermore, patients with CC were grouped into high‐ and low‐risk groups, with the low‐risk group showing higher survival rates. Additionally, these individuals exhibited significant advantages in terms of survival and immunotherapy. Receiver operating characteristic curve analysis demonstrated the higher predictive value of the clinical prognostic gene signature. The outcomes of the validation group depicted congruence with those recorded in the training group. Conclusions: A new model was constructed based on eight OS‐related characteristic genes to aid the prediction of the survival rates of individuals with CC. The present study contributes to the existing literature on the mechanisms of OS genes in CC and offers a fresh perspective for future advancements in immunotherapy for such individuals. [ABSTRACT FROM AUTHOR]